TORRENT PHARMACEUTICALS
Back to All Ratios
|
TORRENT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 35.05 | 29.89 | 26.60 | 19.66 | 19.38 |
What is the latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2026 | 35.05 |
| Mar2025 | 29.89 |
| Mar2024 | 26.60 |
| Mar2023 | 19.66 |
| Mar2022 | 19.38 |
How is EV/Core EBITDA of TORRENT PHARMACEUTICALS Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2026 | 35.05 | 17.26 | |
| Mar2025 | 29.89 | 12.37 | |
| Mar2024 | 26.6 | 35.30 | |
| Mar2023 | 19.66 | 1.44 | |
| Mar2022 | 19.38 | - | |
Other Financial Ratios of TORRENT PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹190,123.9 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| MANKIND PHARMA | ₹101,267.0 Cr | -4.9% | -3.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.6% |
3% |
33.5% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses